E-LIB Suche - Ergebnisse für: Warner, T.T.

1

Novel clinicopathological characteristics differentiate dem..:

Hansen, D. ; Ling, H. ; Lashley, T....
Neuropathology and Applied Neurobiology. 47 (2020) 1 - p. 143-156 , 2020

Link: https://doi.org/10.1111/..

2

Review: Clinical, neuropathological and genetic features of..:

Hansen, D. ; Ling, H. ; Lashley, T...
Neuropathology and Applied Neurobiology. 45 (2019) 7 - p. 635-654 , 2019

Link: https://doi.org/10.1111/..

3

Identification of candidate cerebrospinal fluid biomarkers ..:

Magdalinou, N.K. ; Noyce, A.J. ; Pinto, R....
Parkinsonism & Related Disorders. 37 (2017) - p. 65-71 , 2017

Link: https://doi.org/10.1016/..

4

The role of torsinA in dystonia:

Granata, A. ; Warner, T. T.
European Journal of Neurology. 17 (2010) s1 - p. 81-87 , 2010

Link: https://doi.org/10.1111/..

5

Toward a climate downscaling for the Eastern Mediterranean ..:

Hahmann, A. N. ; Rostkier-Edelstein, D. ; Warner, T. T....
Advances in Geosciences. 12 (2008) - p. 159-164 , 2008

Link: https://doi.org/10.5194/..

6

DYSTONIA:

, In: Neurology and Clinical Neuroscience,

Warner, T.T. - p. 443-453 , 2007

Link: https://doi.org/10.1016/..

7

Increased rate of whole-brain atrophy over 6 months in earl..:

Henley, S.M.D. ; Frost, C. ; MacManus, D. G....
Neurology. 67 (2006) 4 - p. 694-696 , 2006

Link: https://doi.org/10.1212/..

8

CDIP-58 can measure the impact of botulinum toxin treatment..:

Cano, S. J. ; Hobart, J. C. ; Edwards, M....
Neurology. 67 (2006) 12 - p. 2230-2232 , 2006

Link: https://doi.org/10.1212/..

9

High-dose creatine therapy for Huntington disease: A 2-year..:

Tabrizi, S. J. ; Blamire, A. M. ; Manners, D. N....
Neurology. 64 (2005) 9 - p. 1655-1656 , 2005

Link: https://doi.org/10.1212/..

10

Capturing the true burden of dystonia on patients: The Cerv..:

Cano, S. J. ; Warner, T. T. ; Linacre, J. M....
Neurology. 63 (2004) 9 - p. 1629-1633 , 2004

Link: https://doi.org/10.1212/..

11

A clinical and genetic study of SPG5A linked autosomal rece..:

Wilkinson, P.A. ; Crosby, A.H. ; Turner, C....
Neurology. 61 (2003) 2 - p. 235-238 , 2003

Link: https://doi.org/10.1212/..

12

SPG3A mutation screening in English families with early ons..:

Wilkinson, P.A. ; Hart, P.E. ; Patel, H...
Journal of the Neurological Sciences. 216 (2003) 1 - p. 43-45 , 2003

Link: https://doi.org/10.1016/..

13

Creatine therapy for Huntington's disease: Clinical and MRS..:

Tabrizi, S.J. ; Blamire, A.M. ; Manners, D.N....
Neurology. 61 (2003) 1 - p. 141-142 , 2003

Link: https://doi.org/10.1212/..

14

A polymorphism in the dopamine receptor DRD5 is associated ..:

Misbahuddin, A. ; Placzek, M.R. ; Chaudhuri, K.R....
Neurology. 58 (2002) 1 - p. 124-126 , 2002

Link: https://doi.org/10.1212/..

15

Abnormal in vivo skeletal muscle energy metabolism in Hunti..:

Lodi, R. ; Schapira, A. H. V. ; Manners, D....
Annals of Neurology. 48 (2000) 1 - p. 72-76 , 2000

Link: https://doi.org/10.1002/..